###begin article-title 0
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides posadasii </italic>
###xml 0 22 <span type="species:ncbi:199306">Coccidioides posadasii</span>
Coccidioides posadasii infection alters the expression of pulmonary surfactant proteins (SP)-A and SP-D
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 48 61 48 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides </italic>
###xml 520 533 520 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides </italic>
Coccidioidomycosis or Valley Fever is caused by Coccidioides in Southwest US and Central America. Primary pulmonary infection is initiated by inhalation of air-borne arthroconidia. Since, lung is the first organ that encounters arthroconidia, different components of the pulmonary innate immune system may be involved in the regulation of host defense. Pulmonary surfactant proteins (SP)-A and SP-D have been recognized to play an important role in binding and phagocytosis of various microorganisms, but their roles in Coccidioides infection are not known.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 109 132 109 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides posadasii </italic>
###xml 254 267 254 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 93 99 <span type="species:ncbi:10090">murine</span>
###xml 109 131 <span type="species:ncbi:199306">Coccidioides posadasii</span>
###xml 198 202 <span type="species:ncbi:10090">Mice</span>
###xml 254 266 <span type="species:ncbi:199306">C. posadasii</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
In this study, we studied the changes in amounts of pulmonary SP-A, SP-D and phospholipid in murine model of Coccidioides posadasii infection, and binding of SP-A and SP-D to Coccidioidal antigens. Mice were challenged intranasally with a lethal dose of C. posadasii (n = 30 arthroconidia) and bronchoalveolar lavage fluid (BALF) samples were collected on day 10, post infection. In another group of animals, mice were immunized with protective formalin killed spherule (FKS) vaccine prior to infection. The concentrations of BALF SP-A, SP-D, total phospholipid were measured using enzyme linked immunosorbent assay and biochemical assays.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 41 54 41 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 372 385 372 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 41 53 <span type="species:ncbi:199306">C. posadasii</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 372 384 <span type="species:ncbi:199306">C. posadasii</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
We found that in lavage fluid samples of C. posadasii infected mice, the concentrations of total phospholipid, SP-A and SP-D were 17 % (SEM 3.5, p < 0.001), 38 % (SEM 5.8, p < 0.001) and 4 % (SEM 1.3, p < 0.001) of those in lavage fluid samples of non-infected control mice, respectively. However, the concentrations of SP-A and SP-D remained unchanged in BALF samples of C. posadasii protected mice after immunization with FKS vaccine. Also, we found that both SP-A and SP-D bind to Coccidiodal antigens.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 29 42 29 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 29 41 <span type="species:ncbi:199306">C. posadasii</span>
Our results suggest that the C. posadasii infection perturbs the pulmonary SP-A, SP-D, and phospholipids, potentially enabling the disease progression and promoting fungal dissemination.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 108 129 108 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides immitis </italic>
###xml 132 142 132 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">posadasii </italic>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 243 269 243 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii or C. immitis</italic>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 695 696 695 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 787 800 787 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides </italic>
###xml 801 802 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 960 972 960 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides</italic>
###xml 108 128 <span type="species:ncbi:5501">Coccidioides immitis</span>
###xml 243 255 <span type="species:ncbi:199306">C. posadasii</span>
###xml 259 269 <span type="species:ncbi:5501">C. immitis</span>
###xml 687 693 <span type="species:ncbi:9606">people</span>
Coccidioidomycosis or Valley Fever is a fungal disease caused by the biphasic, highly virulent, soil-fungus Coccidioides immitis or posadasii [1]. It is endemic in the southwest regions of US, Northern Mexico and parts of Central America [2]. C. posadasii or C. immitis, are the most virulent fungal pathogens enlisted in Select Agent list and pose a risk for bioterrorism [3]. The primary infection is acquired by inhalation of air-borne, mycelial phase arthroconidium that converts into endosporulating spherule in the lung. Clinical manifestations of the disease range from pulmonary infection to a more severe fatal mycosis involving extra-pulmonary tissues in 1-10% of the infected people [1-4]. Previous studies suggest that Th1 cell mediated immunity protects individuals against Coccidioides [5,6]. However, information is lacking regarding the pulmonary innate immune components that may play a critical role in regulation of immune responses against Coccidioides.
###end p 11
###begin p 12
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 809 822 809 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococci </italic>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 828 851 828 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa </italic>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1183 1184 1183 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1185 1187 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1358 1360 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
###xml 828 850 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
At alveolar level in the lung, the innate immune system is composed of many cell types and chemical mediators, including surfactant. The pulmonary surfactant is a complex mixture of lipids (88-90%) and proteins (10-12%), synthesized by type II epithelial cells and Clara cells. It lines the alveoli, and helps in maintaining normal lung function [7]. Among four different surfactant proteins, surfactant proteins-A (SP-A) and D (SP-D) are members of the "Collectin" family [8]. In the past, several studies have suggested that both SP-A and SP-D play an important role in innate host defense against various viral, fungal and bacterial pathogens [9,10]. More evidence for the pulmonary collectins' role in host defense comes from studies on SP-A- deficient mice that are susceptible to intra-tracheal Group B Streptococci [11], Pseudomonas aeruginosa [12], and Respiratory Syncytial Virus [13]. Also, intranasally administered SP-D has been found to reduce replication of Respiratory Syncytial Virus in the lungs of infected mice [14]. Both SP-A and SP-D, have been classified as secretory pattern-recognition receptors that can bind to a variety of pathogens and help in clearance [9,15]. Recent evidences indicate that in addition to their pathogen recognition property, SP-A and SP-D also play an important role in stimulating immuno-regulatory pathways [15]. However, the collectins' role in coccidioidomycosis is not known.
###end p 12
###begin p 13
###xml 166 179 166 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 183 196 183 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 166 178 <span type="species:ncbi:199306">C. posadasii</span>
###xml 183 195 <span type="species:ncbi:199306">C. posadasii</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
This study focuses on analyzing the changes in amounts of the SP-A and SP-D in the bronchoalveolar lavage fluid (BALF) samples from mice infected with lethal dose of C. posadasii and C. posadasii protected mice after immunization with protective formalin killed spherule (FKS) vaccine, and binding of pulmonary collectins to Coccidioidal antigens.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 15
###begin p 16
###xml 149 162 149 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 276 288 276 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii</italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
###xml 149 161 <span type="species:ncbi:199306">C. posadasii</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 276 288 <span type="species:ncbi:199306">C. posadasii</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">Mice</span>
BALB/c and C57BL6 mice (6 weeks old female) from Jackson Laboratory (Bar Harbour, ME) were used in this study. Both mouse strains are susceptible to C. posadasii infection. The BALB/c mice were used to study the changes in pulmonary surfactant after intranasal challenge with C. posadasii. And, the C57BL6 mice were used to study the changes in pulmonary surfactant after vaccination with protective FKS vaccine. Mice were housed in Biosafety Level-3 animal facility at UTHSCSA and provided with food and water ad libitum. All experimental animal care and treatment protocols were reviewed and approved by Institutional Animal Care and Use Committee.
###end p 16
###begin title 17
###xml 0 22 <span type="species:ncbi:199306">Coccidioides posadasii</span>
Coccidioides posadasii
###end title 17
###begin p 18
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. immitis </italic>
###xml 16 25 16 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">posadasii</italic>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 582 595 582 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 0 10 <span type="species:ncbi:5501">C. immitis</span>
###xml 74 79 <span type="species:ncbi:4932">yeast</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 366 372 <span type="species:ncbi:3635">cotton</span>
###xml 582 594 <span type="species:ncbi:199306">C. posadasii</span>
C. immitis (now posadasii) Silveira strain, cultured on 1 % glucose-0.5 % yeast extract agar (GYE), was used for infecting the mice [1]. The arthroconidia were harvested in endotoxin-free 0.15 M saline (Baxter Health Care Products, Deerfield, IL) from 6-8 weeks old mycelial phase cultures grown on GYE plates. The arthroconidia suspension was passed over a sterile cotton column to remove hyphal elements and arthroconidia were enumerated by hemacytometer counts. The viable cfu counts were confirmed pre- and post-infection by plate cultures on GYE agar. All the experiments with C. posadasii were carried out in Biosafety Level-3 facility at UTHSCSA.
###end p 18
###begin title 19
###xml 26 39 26 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 26 38 <span type="species:ncbi:199306">C. posadasii</span>
Intranasal Challenge with C. posadasii Arthroconidia
###end title 19
###begin p 20
###xml 242 255 240 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 242 254 <span type="species:ncbi:199306">C. posadasii</span>
###xml 388 392 <span type="species:ncbi:10090">Mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
Mice were anaesthetized after intramuscular injection of ketamine- xylazine (75 mug/g body weight ketamine and 10 mug/g body weight xylazine) and were then challenged intranasally with a lethal dose of arthroconidia (n = 30, fresh harvest of C. posadasii arthroconidia) suspended in endotoxin-free 0.15 M NaCl (Baxter Health Care Corp, Deerfield, IL) using sterile pyrogen-free microtip. Mice were held in an upright position for 1-2 min to resume normal breathing after injection. Control mice were challenged with equal volume of endotoxin-free 0.15 M NaCl.
###end p 20
###begin title 21
###xml 15 26 15 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioide</italic>
###xml 59 63 <span type="species:ncbi:10090">Mice</span>
Preparation of Coccidioide-FKS vaccine and Immunization of Mice
###end title 21
###begin p 22
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Silveira</italic>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 242 244 236 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 669 682 663 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 0 12 <span type="species:ncbi:199306">C. posadasii</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 669 681 <span type="species:ncbi:199306">C. posadasii</span>
C. posadasii (strain Silveira)arthroconidia were used to prepare FKS as described earlier [16]. Briefly, arthroconidia were inoculated in modified Converse medium containing Tamol and cultured while shaking at 180 rpm at 40degreesC in 20 % CO2 incubator. The spherules were collected from the harvested culture, washed in endotoxin-free water and killed with 1 % formalin. FKS preparation was checked for sterility and lyophilized. C57BL6 female mice (age 6 weeks old) were immunized intramuscularly twice and subcutaneously once at one week interval with FKS (0.7 mg/dose each time). The mice in FKS immunized, infected group were then challenged intranasally with 30 C. posadasii arthroconidia, 15 days after last immunization, as described above.
###end p 22
###begin title 23
Fungal Burden Assay
###end title 23
###begin p 24
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were anaesthetized as mentioned above, prior to sacrifice on day 10, post intranasal infection. This standard procedure was used for intranasal injection since it does not cause respiratory depression during anaesthesia. The lung and spleen tissues were collected in sterile 0.15 M NaCl for studying fungal load.
###end p 24
###begin p 25
The fungal burden was studied by plating ten fold dilutions of lung and spleen homogenates in 0.15 M saline on Mycosel agar plates (BD Biosciences, Franklin Lakes, NJ) and incubating for 72 h at 30degreesC. The cfu counts were recorded and normalized with organ weight.
###end p 25
###begin title 26
Collection and Processing of BALF
###end title 26
###begin p 27
At the time of necropsy, we collected BALF by injecting 1 ml endotoxin-free 0.15 M NaCl solution (Baxter Health Care Corp, Deerfield, IL) three times, via an angiocatheter (BD Biosciences, San Diego, CA) placed in the trachea. The volume of the input solution was kept constant (3 ml total) and approximately, 90-95 % of the solution was recovered consistently. The BALF was centrifuged at 500 rpm for 10 min at 4degreesC to remove cells. The cell free BALF supernatant was filtered through 0.2 mum syringe filters (Nalge Nunc International, Rochester, NY) and stored at -80degreesC for further analysis.
###end p 27
###begin title 28
Total Protein and Lipid Analysis
###end title 28
###begin p 29
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 141 147 <span type="species:ncbi:9913">bovine</span>
The total protein concentration was measured in BALF specimens using micro bicinchonic acid protein assay kit (Pierce, Rockford, IL) against bovine serum albumin (BSA) standard protein. The total phospholipid content in lipid extracts of BALF specimens was determined using the method of Stewart, against Dipalmitoyl-phosphatidylcholine (DPPC, Avanti Polar Lipids, Alabaster, AL) standard solutions [17,18]. Briefly, the lipid extract of BALF specimens and DPPC standard solutions was completely dried under compressed nitrogen gas. The dried lipids were dissolved in chloroform and mixed with 1 ml of 2.7% ferric chloride and 3% ammonium thiocyanate in glass tubes. The mixture was vortex mixed for 1 min and centrifuged at 200 rpm for 5 min. The bottom red lower layer of phospholipids and ammonium ferro-thiocyanate complex was collected and absorbance was read at 488 nm.
###end p 29
###begin title 30
Western Blotting
###end title 30
###begin p 31
###xml 508 513 <span type="species:ncbi:9606">human</span>
###xml 549 555 <span type="species:ncbi:9986">rabbit</span>
###xml 626 631 <span type="species:ncbi:10090">mouse</span>
###xml 862 868 <span type="species:ncbi:9986">rabbit</span>
###xml 883 887 <span type="species:ncbi:9925">goat</span>
###xml 1037 1042 <span type="species:ncbi:9606">human</span>
###xml 1131 1136 <span type="species:ncbi:9606">human</span>
The BALF and lung tissue homogenate samples (total protein 10-50 mug) were run on 10% sodium dodecyl sulfate- polyacrylamide gel electrophoresis (SDS-PAGE) running gel and transferred on nitrocellulose membranes (Schleicher & Schuell, Keene, NH) overnight at 15 mA current. The nonspecific sites on the membrane with transferred proteins were blocked by 15% nonfat milk in Tris-buffered saline containing 0.05% tween 20 (TBST). The membrane was washed and incubated for 1 h with diluted (1:500) primary anti-human SP-A polyclonal antibody raised in rabbit (obtained from Dr. Richard J. King, UTHSCSA, San Antonio, TX) or anti-mouse SP-D antibody (kindly provided by Dr. Jo Rae Wright, Duke University Medical Center, Durham, NC). After washing the membrane with TBST, the membrane was incubated for 1 h with 1:10,000 diluted alkaline phosphatase conjugated anti-rabbit IgG raised in goat (Sigma Chemical Co, St. Louis, MO). The immunoreactive bands were observed by alkaline phosphatase conjugate system (Biorad, Hercules, CA). Purified human SP-A (kindly provided by Dr. Richard J. King, UTHSCSA, San Antonio, TX) and recombinant human SP-D (kindly provided by Dr. Erika C. Crouch, Washington University in St. Louis, St. Louis, MO) were run with the samples.
###end p 31
###begin p 32
###xml 118 131 118 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 118 130 <span type="species:ncbi:199306">C. posadasii</span>
The Coccidioidal antigens: lysates and filtrates of Coccidioidin (CDN), prepared as a toluene-induced lysate of young C. posadasii mycelia (obtained from Dr. Rebecca A. Cox, UTHSCSA, San Antonio, TX, [19]) were also run to check the cross-reactivities of anti-SP-A and SP-D antibodies to fungal antigens.
###end p 32
###begin title 33
Enzyme-Linked Immunosorbent Assay (ELISA) for SP-A and SP-D
###end title 33
###begin p 34
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 562 563 562 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1187 1188 1186 1187 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1190 1192 1189 1191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
###xml 808 814 <span type="species:ncbi:9986">rabbit</span>
###xml 820 825 <span type="species:ncbi:9606">human</span>
###xml 834 840 <span type="species:ncbi:9986">rabbit</span>
###xml 846 851 <span type="species:ncbi:10090">mouse</span>
###xml 896 907 <span type="species:ncbi:3704">horseradish</span>
###xml 935 941 <span type="species:ncbi:9986">rabbit</span>
The concentrations of SP-A and SP-D were measured in BALF samples as described earlier [20]. The antibodies against SP-A and SP-D reacted with 34 kDa (SP-A) and 43 kDa (SP-D) immunroreactive bands in BALF and lung tissue homogenates (Fig 1). For measuring the lavage concentrations of SP-A and SP-D, the indirect ELISA procedure was used [20]. Briefly, the wells of Immulon 4 strips (Dynatech, Chantilly, VA) were coated overnight with purified human SP-A or recombinant human SP-D antigens (standards) and diluted BALF (three different dilutions) in 0.1 M NaHCO3, pH 9.6. The wells were washed three times with deionized water, and nonspecific sites were blocked with a buffer containing 0.25% BSA, 0.05% tween 20, 0.17 M boric acid and 0.12 M NaCl, pH 8.5. The wells were washed and incubated for 2 h with rabbit anti-human SP-A or rabbit anti-mouse SP-D antibody. After washing the wells, the horseradish peroxidase conjugated anti-rabbit IgG antibody (Sigma, St. Louis, MO) was added. After incubation for 2 h, the wells were washed again and incubated with tetramethylbenzidine substrate reagent (Sigma Chemical Co. St. Louis, MO). The reaction was stopped by adding 50 mul of 2 N H2SO4 and read at 450 nm spectrophotometrically. The regression coefficient for a least-square linear fit to the standard curve of SP-A and SP-D was 0.99. The limits of detection for SP-A and SP-D were 2 ng/ml.
###end p 34
###begin p 35
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 236 241 <span type="species:ncbi:9606">human</span>
Western blot for (A) SP-A and (B) SP-D proteins in mouse lung. Lanes (a, b): 2.5 mug total lavage fluid protein (c, d): 100 mug of total lung tissue homogenate protein from two healthy, non-infected BALB/c mice, and (e): 10 ng purified human SP-A or recombinant SP-D protein.
###end p 35
###begin title 36
Binding of SP-A and SP-D to Coccidioidal Antigens
###end title 36
###begin p 37
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 277 279 275 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 344 346 341 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 402 404 398 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 692 694 688 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1239 1240 1229 1230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1242 1244 1232 1234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 590 595 <span type="species:ncbi:9606">human</span>
###xml 617 622 <span type="species:ncbi:9606">human</span>
###xml 958 969 <span type="species:ncbi:3704">horseradish</span>
###xml 997 1003 <span type="species:ncbi:9986">rabbit</span>
A microtiter well based method [21] was used to study the SP-A and SP-D interactions with Coccidioidal antigens (CDN-lysate and CDN-filtrate). Briefly, microtiter wells (Immulon 4; Dynatech, Chantilly, VA) were coated with 50 mul of CDN-lysate (10 mug/ml diluted in 0.1 M NaHCO3 buffer, pH 9.6) or CDN-filtrate (10 mug/ml diluted in 0.1 M NaHCO3 buffer, pH 9.6) or BSA (10 mug/ml diluted in 0.1 M NaHCO3 buffer, pH 9.6) at room temperature. The nonspecific binding was blocked with phosphate buffered saline (pH 7.4) containing 0.1% triton-X 100 and 3% nonfat milk (buffer A). The purified human SP-A and recombinant human SP-D diluted in 20 mM Tris (pH 7.4) containing 0.15 M NaCl, 5 mM CaCl2 and 1 mg/ml BSA were then added to the wells and incubated for 3 h at 37degreesC. The wells were then washed with buffer A and incubated for 1 h at room temperature with diluted (1:1000 in buffer A) anti-SP-A and anti-SP-D antibodies. After washing the wells, the horseradish peroxidase conjugated anti-rabbit IgG antibody (Sigma, St. Louis, MO) was added. After incubation for 2 h, the wells were washed again and incubated with tetramethylbenzidine substrate reagent (Sigma Chemical Co. St. Louis, MO). The reaction was stopped by adding 2 N H2SO4 and read at 405 nm spectrophotometrically.
###end p 37
###begin p 38
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 230 233 <span type="species:ncbi:10116">rat</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
The coating of Coccidioidal antigens (CDN-lysate and CDN-filtrate) to the plates was confirmed using a positive control antibody that recognizes Coccidioidal antigens as described earlier [22]. The alkaline phosphatase-conjugated rat anti-mouse IgG antibody (Zymed, San Francisco, CA) served as secondary detection antibody.
###end p 38
###begin title 39
Statistics
###end title 39
###begin p 40
Statistical analyses of the data (t-test or ANOVA) were done using Prism Software (Graphpad Software, San Diego, CA). The p value <0.05 was considered significant.
###end p 40
###begin title 41
Results
###end title 41
###begin title 42
Pathological status
###end title 42
###begin p 43
###xml 11 24 11 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 282 295 282 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 11 23 <span type="species:ncbi:199306">C. posadasii</span>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 282 294 <span type="species:ncbi:199306">C. posadasii</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
All of the C. posadasii infected mice survived till the day of sacrifice (day 10 post infection). However, the mice were lethargic and lost body weight (Table 1). Abscess like lesions were quite evident on gross examination of the lung. The total wet lung weights were increased in C. posadasii infected mice.
###end p 43
###begin p 44
###xml 20 33 20 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 20 32 <span type="species:ncbi:199306">C. posadasii</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Body weights (g) of C. posadasii infected and non-infected BALB/c mice (n = 10 of each type). Values are shown as Mean (SEM) of one representative experiment of two independent experiments.
###end p 44
###begin p 45
###xml 48 52 <span type="species:ncbi:10090">mice</span>
** p < 0.01 as compared to non-infected control mice at day 0.
###end p 45
###begin p 46
###xml 39 52 39 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 39 51 <span type="species:ncbi:199306">C. posadasii</span>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
*p < 0.05, # p < 0.0001 as compared to C. posadasii infected mice at day 0 and non-infected mice at day 10, respectively (t-test).
###end p 46
###begin p 47
###xml 214 215 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 295 308 293 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 295 307 <span type="species:ncbi:199306">C. posadasii</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
The mean protein content of BALF samples from infected mice was 788 mug versus 326 mug protein in BALF samples from non-infected saline injected control mice, after 10 days of intranasal infection (p < 0.05, Table 2). In contrast, the phospholipid concentration was reduced in BALF samples from C. posadasii infected mice (58 mug) when compared to non-infected saline injected controls (165 mug, p < 0.05).
###end p 47
###begin p 48
###xml 78 91 78 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 78 90 <span type="species:ncbi:199306">C. posadasii</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Total protein and phospholipid contents in BALF samples from non-infected and C. posadasii infected BALB/c mice (n = 5 of each type). Values are shown as Mean (SEM) from one represenative experiment of two independent experiments.
###end p 48
###begin p 49
###xml 47 51 <span type="species:ncbi:10090">mice</span>
* p < 0.05 as compared to non-infected control mice (t-test).
###end p 49
###begin title 50
###xml 76 89 76 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 76 88 <span type="species:ncbi:199306">C. posadasii</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
The amounts of SP-A, SP-D and phospholipid are reduced in BALF samples from C. posadasii infected mice
###end title 50
###begin p 51
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 678 691 678 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 984 997 984 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 678 690 <span type="species:ncbi:199306">C. posadasii</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 984 996 <span type="species:ncbi:199306">C. posadasii</span>
The anti-human-SP-A and anti-mouse SP-D antibodies recognized 34 kDa and 43 kDa monomer bands of SP-A and SP-D in BALF and lung tissue samples (Fig 1). The upper bands of approximately 68 kDa and 85 kDa size (dimer of SP-A and SP-D protein) were also visible in lanes e of Figure 1A and 1B due to incomplete reduction, respectively. There were no differences in the detectable isoforms of SP-A or SP-D in the BALF samples from infected mice as compared to non-infected control mice (data not shown). The antibodies did not cross-react with Coccidioidal antigens in CDN lysate or CDN filtrate (Fig 2). The amounts of SP-A and SP-D were significantly reduced in BALF samples from C. posadasii infected BALB/c mice when compared to saline injected, non-infected control mice after 10 days of intranasal challenge (p < 0.001) (Fig 3A). No significant changes were observed in the amounts of SP-A and SP-D in BALF samples collected from BALB/c mice, 5 days after intranasal challenge with C. posadasii (data not shown).
###end p 51
###begin p 52
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
###xml 288 293 <span type="species:ncbi:9606">human</span>
Western blot of CDN-lysate and CDN-filtrate for crossreactivity with (A) anti-human SP-A and (b) anti-mouse SP-D antibodies. Lanes (a): 20 mug, (b): 10 mug and (c): 1 mug CDN-filtrate protein. Lanes (d): 20 mug, (e): 10 mug and (f): 1 mug CDN-lysate protein and last lane: 10 ng purified human SP-A protein or recombinant SP-D protein.
###end p 52
###begin p 53
###xml 46 59 46 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 168 181 167 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 46 58 <span type="species:ncbi:199306">C. posadasii</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 168 180 <span type="species:ncbi:199306">C. posadasii</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
SP-A and SP-D levels in BALF samples from (A) C. posadasii infected BALB/c mice (ng/mug protein, % of non-infected control mice, n = 5 of each type) (B) FKS immunized, C. posadasii infected C57BL6 mice (protected mice) (ng/mug protein, % of FKS immunized non-infected mice, n = 5 of each type). The data are shown from one representative experiment of two independent experiments. * p < 0.001 (ANOVA)
###end p 53
###begin p 54
###xml 23 36 23 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 222 238 222 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii to </italic>
###xml 23 35 <span type="species:ncbi:199306">C. posadasii</span>
###xml 222 234 <span type="species:ncbi:199306">C. posadasii</span>
The fungal colonies of C. posadasii were recovered from both lung and spleens of infected animals indicating the presence of active infection (Fig 4). Recovery of fungus in the spleen provides evidence of dissemination of C. posadasii to extra-pulmonary organs.
###end p 54
###begin p 55
###xml 46 59 46 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 46 58 <span type="species:ncbi:199306">C. posadasii</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Fungal load in the lung and spleen tissues of C. posadasii infected BALB/c mice (n = 5). The numbers of fungal colonies (CFU) were normalized with organ weight (g).
###end p 55
###begin title 56
###xml 45 58 45 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 45 57 <span type="species:ncbi:199306">C. posadasii</span>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Lavage SP-A and SP-D levels are unaltered in C. posadasii protected mice
###end title 56
###begin p 57
###xml 101 114 101 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 307 320 307 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 101 113 <span type="species:ncbi:199306">C. posadasii</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 307 319 <span type="species:ncbi:199306">C. posadasii</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
No significant changes were seen in SP-A or SP-D levels in BALF samples of protected (FKS immunized, C. posadasii arthroconidia infected) C57BL6 mice when compared to FKS immunized, non-infected mice (Fig 3B). Also, there was no significant change in total protein content in BALF samples of FKS immunized, C. posadasii arthroconidia infected mice (890.9 mug) versus FKS immunized, non-infected mice (538.4 mug).
###end p 57
###begin title 58
SP-A and SP-D bind to Coccidioidal antigens
###end title 58
###begin p 59
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 417 419 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 570 572 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
We further examined the binding of SP-A and SP-D to Coccidioidal antigens (CDN-lysate and CDN-filtrate) coated onto microtiter wells (Fig 5). Both SP-A and SP-D bound to coccidioidal antigens, but not to BSA in a concentration-dependent manner (Fig 5). Binding of SP-A to CDN-lysate and CDN-filtrate antigens was saturable, and maximum SP-A binding was reached between 2.5-5 mug/ml and 5-10 mug/ml, respectively (Fig 5A). Similarly binding of SP-D to CDN-lysate and CDN-filtrate antigens was also saturable, and maximum SP-D binding was reached between 5-10 mug/ml (Fig 5B).
###end p 59
###begin p 60
###xml 125 130 <span type="species:ncbi:9606">human</span>
Binding of (A) SP-A and (B) SP-D to Coccidioidal antigens (CDN-lysate and CDN-filtrate). The binding of 1-10 mug/ml purified human SP-A or recombinant SP-D proteins was detected in CDN-lysate or CDN-filtrate or BSA coated wells (0.5 mug/well). Results are from one representative experiment of two independent experiments performed in duplicate. Values are shown as mean+SEM. In some cases, the error bars are smaller than the symbols.
###end p 60
###begin title 61
Discussion
###end title 61
###begin p 62
###xml 110 123 110 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 166 179 166 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 458 471 458 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 631 644 631 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 774 786 774 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii</italic>
###xml 909 930 909 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 934 958 934 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans </italic>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 964 986 964 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus fumigatus </italic>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 995 1012 995 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1049 1061 1049 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1178 1180 1178 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1274 1287 1274 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. fumigatus </italic>
###xml 1299 1313 1299 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1354 1356 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1357 1359 1357 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1582 1595 1582 1595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. fumigatus </italic>
###xml 1596 1598 1596 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1649 1662 1649 1662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 1860 1873 1860 1873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 110 122 <span type="species:ncbi:199306">C. posadasii</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 166 178 <span type="species:ncbi:199306">C. posadasii</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 458 470 <span type="species:ncbi:199306">C. posadasii</span>
###xml 631 643 <span type="species:ncbi:199306">C. posadasii</span>
###xml 774 786 <span type="species:ncbi:199306">C. posadasii</span>
###xml 909 929 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 934 946 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 934 957 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 964 985 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 995 1011 <span type="species:ncbi:5476">Candida albicans</span>
###xml 1049 1060 <span type="species:ncbi:5476">C. albicans</span>
###xml 1274 1286 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 1299 1312 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1563 1567 <span type="species:ncbi:10090">mice</span>
###xml 1582 1594 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 1649 1661 <span type="species:ncbi:199306">C. posadasii</span>
###xml 1727 1731 <span type="species:ncbi:10090">mice</span>
###xml 1860 1872 <span type="species:ncbi:199306">C. posadasii</span>
In the present study we found that the levels of pulmonary surfactant collectins were altered in the lungs of C. posadasii infected mice, but were intact in lungs of C. posadasii protected mice after immunization with protective FKS vaccine. Furthermore, our results suggest that both SP-A and SP-D bind to Coccidioidal antigens. This is the first study where the amounts of SP-A and SP-D were measured in BALF samples from mice infected with lethal dose of C. posadasii and the binding of pulmonary collectins to Coccidioidal antigens was assessed. Since lung is the first organ of the body that comes into contact with air-borne C. posadasii arthroconidia, we hypothesized that the pulmonary surfactant may play an important role in regulating the immune response against C. posadasii. Among four surfactant proteins, SP-A and SP-D, interact with most of the clinically important fungal pathogens including Pneumocystis carinii [23]Cryptococcus neoformans [24], Aspergillus fumigatus [25] and Candida albicans [26]. SP-D has been shown to bind to C. albicans and directly inhibit growth by aggregation of the organism without involvement of macrophage dependent phagocytosis [27]. On the other hand, surfactant proteins also induce phagocytosis, activation and killing of A. fumigatus conidia and C. neoformans by alveolar macrophages and neutrophils [28,29]. In support of these findings, further evidence comes from a study by Madan et al., that suggests that the introduction of recombinant SP-D improves the lung function and increases the survival rate of mice infected with A. fumigatus [25]. The decrease in amounts of SP-A and SP-D during C. posadasii infection versus the unaltered amounts in the lungs of protected mice and binding of collectins to Coccidioidal antigens indicate that pulmonary collectins may be involved in uptake/phagocytosis of C. posadasii by antigen presenting cells and downstream immune regulation.
###end p 62
###begin p 63
###xml 113 126 113 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 327 348 327 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 766 779 766 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 846 859 846 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 1077 1090 1070 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 1380 1382 1369 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1383 1385 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1455 1468 1444 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 1505 1506 1494 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1910 1912 1899 1901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 113 125 <span type="species:ncbi:199306">C. posadasii</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10116">rats</span>
###xml 306 312 <span type="species:ncbi:9606">humans</span>
###xml 327 347 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 551 557 <span type="species:ncbi:10090">murine</span>
###xml 766 778 <span type="species:ncbi:199306">C. posadasii</span>
###xml 846 858 <span type="species:ncbi:199306">C. posadasii</span>
###xml 1077 1089 <span type="species:ncbi:199306">C. posadasii</span>
###xml 1455 1467 <span type="species:ncbi:199306">C. posadasii</span>
###xml 1478 1482 <span type="species:ncbi:10090">mice</span>
Besides changes in amounts of SP-A and SP-D, a decrease in the amount of BALF phospholipids was also observed in C. posadasii infected mice (Table 2). Earlier, Sheehan et al., [29] and Hoffman et al., [30] have reported similar findings of reduced surfactant phospholipid level in BALF samples of rats and humans infected with Pneumocystis carinii [29,30]. To date, however, the information is lacking concerning how surfactant phospholipids may be involved in host defense [31]. Likewise, the mechanisms underlying the decrease of BALF surfactant in murine model of Coccidioidomycosis remain to be defined. We speculate that the reduction in the collectins and phospholipids could be either due to metabolic dysfunction of pulmonary type II epithelial cells during C. posadasii infection or due to their utilization in the binding and uptake of C. posadasii by local antigen presenting cells. The metabolic pathways of pulmonary type II epithelial cells may be affected by secondary inflammatory mediators, such as TNF-alpha or IL-1beta, secreted by inflammatory cells during C. posadasii infection. A variety of host inflammatory mediators and substances such as, cytokines (TNF-alpha) and growth factors are released during infection and inflammation. These cytokines and growth factors affect the synthesis and secretion of pulmonary surfactant by pulmonary epithelial cells [32,33]. In the present study we found slightly increased levels of SP-D in C. posadasii protected mice, but not of SP-A (Fig 2). We speculate that the difference could be due to diverse mechanisms for regulation of SP-A and SP-D expression. Probably the cytokines and chemokines that are released as a result of FKS vaccination (protective immune response) increase the SP-D expression, but do not affect the SP-A expression. As reported earlier, the expression of SP-A and SP-D is differentially regulated during lung infection [34]. In future, more studies are warranted to understand the mechanism of the alterations in levels of surfactant phospholipids, SP-A and SP-D.
###end p 63
###begin p 64
###xml 29 42 29 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 298 311 298 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides </italic>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 476 489 476 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 493 504 493 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. immitis </italic>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 29 41 <span type="species:ncbi:199306">C. posadasii</span>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 324 330 <span type="species:ncbi:10090">murine</span>
###xml 374 380 <span type="species:ncbi:9606">humans</span>
###xml 476 488 <span type="species:ncbi:199306">C. posadasii</span>
###xml 493 503 <span type="species:ncbi:5501">C. immitis</span>
At present, the treatment of C. posadasii infected patients with disseminated disease is not very effective [35]. Treatment with anti-fungal agents is most often related to relapse of the infection and side effects on the body. Earlier, the FKS based immunization has been found protective against Coccidioides infection in murine model of coccidioidomycosis, but failed in humans [35]. More pre-clinical studies on developing different vaccine strategies are underway. Since C. posadasii and C. immitis are highly virulent organisms, cause endemic infection, and pose a risk for bioterrorism, there is an urgent need for discovery of improved therapeutic drugs and regimens or preventive vaccines [3,35].
###end p 64
###begin title 65
Conclusions
###end title 65
###begin p 66
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 101 114 101 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 366 379 366 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. posadasii </italic>
###xml 101 113 <span type="species:ncbi:199306">C. posadasii</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 366 378 <span type="species:ncbi:199306">C. posadasii</span>
In future, clearance experiments after in vivo administration of artificial or natural surfactant in C. posadasii infected mice may be useful in determining their therapeutic usefulness. We speculate that the findings from our present study would initiate similar studies to understand the role of pulmonary innate immune components in infectious diseases caused by C. posadasii or other virulent respiratory pathogens.
###end p 66
###begin title 67
Authors' Contributions
###end title 67
###begin p 68
###xml 166 170 <span type="species:ncbi:10090">mice</span>
SA designed and co-ordinated the study, performed assays and statistical analysis and drafted the manuscript. JJC assessed lung pathology. DMM prepared and immunized mice with FKS. All authors read and approved the final manuscript.
###end p 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
Authors acknowledge the technical assistance of Adrian Donias and Amy Chein in animal studies. We also thank Dr. Rebecca A. Cox (UTHSCSA, San Antonio, TX), Dr. Richard J. King (UTHSCSA, San Antonio, TX, now retired), Dr. Erika C. Crouch (Washington University in St. Louis, St. Louis, MO) and Dr. Jo Rae Wright (Duke University Medical Center, Durham, NC) for providing us with coccidioidal antigens, SP-A and SP-D antigens and antibodies. This work is supported by research grants from San Antonio Area Foundation from Semp Russ Foundation, and California Health Care Foundation, the Department of Health Services of the State of California, California State University at Bakersfield.
###end p 70
###begin article-title 71
###xml 40 63 40 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides posadasii </italic>
###xml 131 151 131 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides immitis</italic>
###xml 40 62 <span type="species:ncbi:199306">Coccidioides posadasii</span>
###xml 131 151 <span type="species:ncbi:5501">Coccidioides immitis</span>
Molecular and phenotypic description of Coccidioides posadasii sp. Nov., previously recognized as the non-California population of Coccidioides immitis
###end article-title 71
###begin article-title 72
Epidemiology of coccidioidomycosis
###end article-title 72
###begin article-title 73
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides immitis </italic>
###xml 0 20 <span type="species:ncbi:5501">Coccidioides immitis</span>
Coccidioides immitis as a select agent of bioterrorism
###end article-title 73
###begin article-title 74
Coccidioidomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates
###end article-title 74
###begin article-title 75
###xml 42 63 42 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides immitis </italic>
###xml 42 62 <span type="species:ncbi:5501">Coccidioides immitis</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Mechanism of resistance to infection with Coccidioides immitis in mice
###end article-title 75
###begin article-title 76
###xml 64 69 <span type="species:ncbi:9606">human</span>
In vitro modulation of proliferation and cytokine production by human peripheral blood mononuclear cells from subjects with various forms of coccidioidomycosis
###end article-title 76
###begin article-title 77
Pulmonary surfactant
###end article-title 77
###begin article-title 78
Collectins, soluble proteins containing collagenous regions and lectin domains, and their roles in innate immunity
###end article-title 78
###begin article-title 79
Collectins and ficolins: Humoral lectins of the innate immune defense
###end article-title 79
###begin article-title 80
Surfactant protein-D and pulmonary host defense
###end article-title 80
###begin article-title 81
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Surfactant protein -A deficient mice are susceptible to group B streptococcal infection
###end article-title 81
###begin article-title 82
###xml 56 79 56 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa </italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 56 78 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Surfactant protein -A deficient mice are susceptible to Pseudomonas aeruginosa infection
###end article-title 82
###begin article-title 83
Surfactant protein -A enhances repiratory syncytial virus clearance in vivo
###end article-title 83
###begin article-title 84
###xml 85 112 <span type="species:ncbi:12814">respiratory syncytial virus</span>
A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo
###end article-title 84
###begin article-title 85
Immunomodulatory functions of surfactant
###end article-title 85
###begin article-title 86
###xml 23 44 23 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides immitis </italic>
###xml 23 43 <span type="species:ncbi:5501">Coccidioides immitis</span>
Growth of spherules of Coccidioides immitis in a chemically defined liquid medium
###end article-title 86
###begin article-title 87
A rapid method of total lipid extraction and purification
###end article-title 87
###begin article-title 88
Colorimetric determination of phospholipids with ammonium ferrothiocyanate
###end article-title 88
###begin article-title 89
###xml 42 62 42 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides immitis</italic>
###xml 42 62 <span type="species:ncbi:5501">Coccidioides immitis</span>
Studies of antigens from young mycelia of Coccidioides immitis
###end article-title 89
###begin article-title 90
###xml 41 48 <span type="species:ncbi:9557">Baboons</span>
Surfactant Proteins A and D in Premature Baboons with Chronic Lung Injury (Bronchopulmonary Dysplasia). Evidence for an Inhibition of Secretion
###end article-title 90
###begin article-title 91
Surfactant protein A inhibts peptidoglycan-induced tumor necrosis factor-a secretion in U937 cells and alveolar macrophages by direct interaction with Toll-like receptor 2
###end article-title 91
###begin article-title 92
###xml 123 143 123 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides immitis</italic>
###xml 123 143 <span type="species:ncbi:5501">Coccidioides immitis</span>
Coadministration of interleukin 12 expression vector with Antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis
###end article-title 92
###begin article-title 93
###xml 36 57 36 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 36 56 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages
###end article-title 93
###begin article-title 94
###xml 51 76 51 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans: </italic>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
###xml 51 63 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 51 74 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 139 144 <span type="species:ncbi:4932">yeast</span>
Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells
###end article-title 94
###begin article-title 95
###xml 50 56 <span type="species:ncbi:10090">murine</span>
Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis
###end article-title 95
###begin article-title 96
###xml 57 73 57 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 57 73 <span type="species:ncbi:5476">Candida albicans</span>
Role of pulmonary surfactant D in innate defense against Candida albicans
###end article-title 96
###begin article-title 97
###xml 52 73 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages
###end article-title 97
###begin article-title 98
###xml 85 97 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 85 108 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
In vitro effect of lung surfactant on alveolar macrophage defence mechanisms against Cryptococcus neoformans
###end article-title 98
###begin article-title 99
###xml 69 90 69 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 69 89 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia
###end article-title 99
###begin article-title 100
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 51 79 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 94 114 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia
###end article-title 100
###begin article-title 101
###xml 49 55 <span type="species:ncbi:9913">bovine</span>
In vitro lymphocyte functions in the presence of bovine surfactant and its phospholipid fractions
###end article-title 101
###begin article-title 102
Pulmonary-specific expression of tumor necrosis factor-alpha alters surfactant lipid metabolism
###end article-title 102
###begin article-title 103
Transforming growth factor-beta inhibits surfactant protein A expression in vitro
###end article-title 103
###begin article-title 104
###xml 38 43 <span type="species:ncbi:9606">human</span>
Regulation of surfactant protein D in human fetal lung
###end article-title 104
###begin article-title 105
###xml 52 73 52 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Coccidioides immitis </italic>
###xml 52 72 <span type="species:ncbi:5501">Coccidioides immitis</span>
###xml 93 99 <span type="species:ncbi:9606">humans</span>
Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans
###end article-title 105

